Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides

Nutrition Reviews

Volumn 68, Issue 3, 2010, Pages 155-167

  Musa Veloso, Kathy ^a   Binns, Malcolm Angus ^b   Kocenas, Alexandra Catherine ^a   Poon, Theresa ^a   Elliot, Julie Ann ^a   Rice, Harry ^c   Oppedal Olsen, Hilde ^d   Lloyd, Hilary ^e   Lemke, Shawna ^f  

^a Cantox Health Sciences International   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Global Organization for EPA and DHA Omega 3s (GOED)   (United States)

^d Denomega Nutritional Oils AS   (Norway)

^e Ocean Nutrition Canada Ltd   (Canada)

^f MONSANTO COMPANY   (United States)

Author keywords

Docosahexaenoic acid; Eicosapentaenoic acid; Fish oil; Omega 3 fatty acids; Triglycerides

Indexed keywords

CORN OIL; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OLEIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO; SOYBEAN OIL; TRIACYLGLYCEROL;

CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL TRIAL; DIET RESTRICTION; DIET SUPPLEMENTATION; DIETARY INTAKE; DOSE RESPONSE; DRUG EFFICACY; HEART PROTECTION; HUMAN; HYPERTRIGLYCERIDEMIA; LOW DRUG DOSE; MATHEMATICAL MODEL; MEDICAL LITERATURE; PLACEBO EFFECT; PREDICTION; REVIEW; SAMPLE SIZE; SCORING SYSTEM; THERAPY EFFECT; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; HEALTH CARE POLICY; METABOLISM; RANDOMIZED CONTROLLED TRIAL;

DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSAPENTAENOIC ACID; FASTING; HUMANS; NUTRITION POLICY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRIGLYCERIDES;

EID: 77953670912     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2010.00272.x     Document Type: Review

References (51)

1. Assmann G, Schulte H, Cullen P. New and classical risk factors - the Münster heart study (PROCAM). Eur J Med Res. 1997;2:237-242.
2. Assmann G, Cullen P, Schulte H. The Münster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J. 1998;19(Suppl A):A2-A11.
3. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: An eight-year follow-up in the Copenhagen Male Study [published correction appears in Circulation. 1995;97]. Circulation. 1998;97:1029-1036.
4. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of highdensity lipoprotein cholesterol level: A meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213-219.
5. National Cholesterol Education Program (NCEP). Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III: Final Report. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health, National Cholesterol Education Program; 2002. NIH 02-5215. Available at: Http:// www.nhlbi.nih.gov/ guidelines/cholesterol/atp3full.pdf. Accessed 9 June 2009.
6. European Society of Cardiology. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehabil. 2007;14(Suppl):E1-E40, S1-S113.
7. World Health Organization. Cardiovascular Diseases (CVD): Assessment of Risk. Geneva, Switzerland: World Health Organization (WHO); Cairo, Egypt: Regional Office for the Eastern Mediterranean; 2005.
8. Fletcher B, Berra K, Ades P, et al. Managing abnormal blood lipids: A collaborative approach. Circulation. 2005;112:3184-3209.
9. Harris WS. n-3 fatty acids and serum lipoproteins: Human studies. Am J Clin Nutr. 1997;65(Suppl):S1645-S1654.
10. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review. Atherosclerosis. 2006;189:19-30.
11. British Nutrition Foundation (BNF). N-3 Fatty Acids and Health. London: British Nutrition Foundation (BNF); 1999.
12. Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology (ESC). Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2003;24:28-66.
13. Food and Agriculture Organization/World Health Organization. Diet, Nutrition and the Prevention of Chronic Diseases. Report of a Joint WHO/FAO Expert Consultation. Jan. 28-Feb. 1, 2002. Geneva, Switzerland: World Health Organization (WHO); 2003. WHO Technical Report Series, no 916. Available at: Http://whqlibdoc.who.int/trs/WHO-TRS-916.pdf. Accessed 9 June 2009.
14. International Society for the Study of Fatty Acids and Lipids (ISSFAL). Recommendations for Intake of Polyunsaturated Fatty Acids in Healthy Adults. Tiverton, Devon: International Society for the Study of Fatty Acids and Lipids (ISSFAL); 2004. Available at: Http://www.issfal.org.uk/images/stories/pdfs/ PUFAIntakeReccomdFinalReport.pdf. Accessed 9 June 2009.
15. Scientific Advisory Committee on Nutrition (SACN) and Committee on Toxicology (COT). Advice on Fish Consumption: Benefits & Risks. Food Standards Agency (FSA). London: The Stationery Office; 2004. Available at: Http:// www.food.gov.uk/multimedia/pdfs/fishreport2004full.pdf. Accessed 9 June 2009.
16. Institute of Medicine. Macronutrients and healthful diets. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, DC: Institute of Medicine of the National Academies / National Academy Press; 2005. Available at: Http://books.nap.edu/openbook.php?record-id=10490&page=769. Accessed 9 June 2009.
17. Lichtenstein AH, Appel LJ, Brands M, et al. Summary of American Heart Association Diet and Lifestyle Recommendations revision 2006. Arterioscler Thromb Vasc Biol. 2006;26:2186-2191.
18. European Food Safety Authority (EFSA). Scientific opinion of the panel on dietetic products, nutrition and allergies on a request from European Commission related to labelling reference intake values for n-3 and n-6 polyunsaturated fatty acids (Question N̊ EFSA-Q-2009-00548, adopted on 30 June 2009). Parma, Italy: European Food Safety Authority. EFSA J. 2009;1176:1-11.
19. European Food Safety Authority (EFSA). Opinion of the scientific panel on dietetic products, nutrition and allergies on a request from the Commission related to scientific and technical guidance for the preparation and presentation of the application for authorisation of a health claim: Appendix H (Request N̊ EFSA-Q-2007-066). Parma, Italy: European Food Safety Authority. EFSA J. 2007;530:1-44.
20. Wu WH, Lu SC, Wang TF, Jou HJ, Wang TA. Effects of docosahexaenoic acid supplementation on blood lipids, estrogen metabolism, and in vivo oxidative stress in postmenopausal vegetarianwomen. Eur J Clin Nutr. 2006;60:386-392.
21. Chan DC, Watts GF, Mori TA, Barrett PHR, Beilin LJ, Redgrave TG. Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity. Eur J Clin Invest. 2002;32:429-436.
22. Leigh-Firbank EC, Minihane AM, Leake DS, et al. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: Differential associations with lipid responses. Br J Nutr. 2002;87:435-445.
23. Maki KC, Van Elswyk ME,McCarthy D, et al. Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol. J Am Coll Nutr. 2005;24:189-199.
24. Dyerberg J, Eskesen DC, Andersen PW, et al. Effects of transand n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study. Eur J Clin Nutr. 2004;58:1062-1070.
25. Hamazaki K, Itomura M, Huan M, et al. n-3 long-chain FA decrease serum levels of TG and remnant-like particlecholesterol in humans. Lipids. 2003;38:353-358.
26. Hill AM, Buckley JD, Murphy KJ, Howe PRC. Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors.Am J Clin Nutr. 2007;85:1267-1274.
27. Lovegrove JA, Lovegrove SS, Lesauvage SVM, et al. Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians. Am J Clin Nutr. 2004;79:974-982.
28. Maki KC, Van Elswyk ME, McCarthy D, et al. Lipid responses in mildly hypertriglyceridemic men and women to consumption of docosahexaenoic acid-enriched eggs. Int J Vitam Nutr Res. 2003;73:357-368.
29. Stark KD, Holub BJ. Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. Am J Clin Nutr. 2004;79:765-773.
30. Goyens PLL, Mensink RP. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects. Eur J Clin Nutr. 2006;60:978-984.
31. Murphy KJ, Meyer BJ, Mori TA, et al. Impact of foods enriched with n-3 long-chain polyunsaturated fatty acids on erythrocyte n-3 levels and cardiovascular risk factors. Br J Nutr. 2007;97:749-757.
32. Castro IA, Monteiro VCB, Barroso LP, Bertolami MC. Effect of eicosapentaenoic/docosahexaenoic fatty acids and soluble fibers on blood lipids of individuals classified into different levels of lipidemia. Nutrition. 2007;23:127-137.
33. Browning LM, Krebs JD, Moore CS, Mishra GD, O'Connell MA, Jebb SA. The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab. 2007;9:70-80.
34. Buckley R, Shewring B, Turner R, Yaqoob P, Minihane AM. Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects. Br J Nutr. 2004;92:477-483.
35. Laboratory Methods Committee of the Lipid Research Clinics Program. Cholesterol and triglyceride concentrations in serum/plasma pairs. Clin Chem. 1977;23:60-63.
36. Jacobson TA. Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease. Am J Clin Nutr. 2008;87:(Suppl):S1981-S1990.
37. Skulas-Ray AC, West SG, Davidson MH, Kris-Etherton PM. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia. Expert Opin Pharmacother. 2008;9:1-12.
38. Harris WS, Ginsberg HN, Arunakul N, et al. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk. 1997;4:385-391.
39. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: A critical review. J Lipid Res. 1989;30:785-807.
40. Simopoulos AP. Omega-3 fatty acids in health and disease and growth and development. Am J Clin Nutr. 1991;54:438-463.
41. Connor WE, DeFrancesco CA, Connor SL. n-3 fatty acids from fish oil: Effects on plasma lipoproteins and hypertriglyceridemic patients. Ann N Y Acad Sci. 1993;16-34.
42. Friedberg CE, Heine RJ, Janssen MFJM, Grobbee DE. Fish oil and glycemic control in diabetes: A meta-analysis. Diabetes Care. 1998;21:494-500.
43. Lewis NM, Seburg S, Flanagan NL. Enriched eggs as a source of n-3 polyunsaturated fatty acids for humans. Poultry Sci. 2000;79:971-974.
44. Weber P, Raederstorff D. Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids - a review. Nutr Metab Cardiovasc Dis. 2000;10:28-37.
45. Harris WS. Extending the cardiovascular benefits of omega-3 fatty acids. Curr Atheroscler Rep. 2005;7:375-380.
46. Ryan AS, Keske MA, Hoffman JP, Nelson EB. Clinical overview of algal-docosahexaenoic acid: Effects on triglyceride levels and other cardiovascular risk factors. Am J Therap. 2009;16:183-192.
47. Baker SJ, Al-Najadah R. Effect of ingesting fish oil on serum lipid and lipoprotein concentration in exercising and nonexercising women. Sports Med Train Rehab. 1996;6:287-297.
48. Saldeen T, Wallin R, Marklinder I. Effects of a small dose of stable fish oil substituted for margarine in bread on plasma phospholipid fatty acids and serum triglycerides. Nutr Res. 1998;18:1483-1492.
49. Liu M, Wallin R, Saldeen T. Effect of bread containing stable fish oil on plasma phospholipid fatty acids, triglycerides, HDLcholesterol, and malondialdehyde in subjects with hyperlipidemia. Nutr Res. 2001;21:1403-1410.
50. Hänninen OO, Agren JJ, Laitinen MV, Jääskeläinen IO, Penttilä IM. Dose-response relationships in blood lipids during moderate freshwater fish diet. Ann Med. 1989;21:203-207.
51. Castro CM, Halkes CJ, Meijssen S, van Oostrom AJ, Erkelens DW. Diurnal triglyceride profiles: A novel approach to study triglyceride changes. Atherosclerosis. 2001;155:219-228.